Home › Brain Tumors › Colorado › Denver
Brain Tumors clinical trials in Denver, CO
3 studies for Brain Tumors are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- The Women's Imaging Center, Denver
- Colorado Blood Cancer Institute, Denver
- Presbyterian - Saint Lukes Medical Center - Health One, Denver
- and 6 more
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Centura, Denver
- Colorado Brain & Spine Institute: Swedish Campus, Englewood · 6 mi away
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
RecruitingPhase 1/2
- Sarah Cannon Research Institute at HealthOne, Denver
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX37 studies
- Boston, MA29 studies
- New York City, NY25 studies
- Washington, DC21 studies
- Los Angeles, CA17 studies
- Durham, NC15 studies
- Miami, FL14 studies
- Chicago, IL12 studies
- Rochester, MN12 studies
- St. Louis, MO12 studies
- Cleveland, OH11 studies
- Columbus, OH11 studies
Other studies in Denver
- Breast Cancer26 studies
- Multiple Myeloma26 studies
- Non-Small Cell Lung Cancer25 studies
- Metastatic Cancer25 studies
- Colorectal Cancer22 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer17 studies
- Endometrial Cancer15 studies
- Cancer (all types)15 studies
- Lung Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.